These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23982928)

  • 1. Causes and clinical significance of prolonged activated partial thromboplastin times in thalassaemia major.
    McFadyen J; Butler J; Malan E; Tran H
    Ann Hematol; 2014 May; 93(5):867-8. PubMed ID: 23982928
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of coagulation and inflammation activation by chronic blood transfusion in an asplenic patient with haemoglobin E/β-thalassaemia and pulmonary arterial hypertension.
    Chuncharunee S; Atichartakarn V; Archararit N; Aryurachai K
    Transfus Med; 2013 Aug; 23(4):276-8. PubMed ID: 23480175
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
    Rashidi A; Alavi S; Arzanian MT; Ahmadinejad M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion-induced hypoxemia in beta-thalassaemia.
    Tassiopoulos T; Konstantopoulos K; Rombos Y; Pournaras N
    Am J Hematol; 1996 Nov; 53(3):206. PubMed ID: 8895698
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal coagulation parameters in thawed frozen plasma.
    Yea S; Anthony MA; Yuan S
    J Clin Anesth; 2012 Sep; 24(6):505-6. PubMed ID: 22986321
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
    Chang HH; Chen MJ; Lu MY; Chern JP; Lu CY; Yang YL; Jou ST; Lin DT; Yang YS; Lin KH
    BJOG; 2011 Jun; 118(7):825-31. PubMed ID: 21401854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
    Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
    Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human blood coagulation: clinical and laboratory correlation.
    Natelson EA
    Clin Physiol Biochem; 1983; 1(2-5):214-24. PubMed ID: 6680898
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of plasma blood coagulation factor activity by physical stress].
    Lutze G; Buhl H; Häcker R; Socha C; Socha U; Urbahn H
    Z Gesamte Inn Med; 1986 Sep; 41(18):502-5. PubMed ID: 3099480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia.
    Habib A; Kunzelmann C; Shamseddeen W; Zobairi F; Freyssinet JM; Taher A
    Haematologica; 2008 Jun; 93(6):941-2. PubMed ID: 18460647
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.
    Hagar RW; Morris CR; Vichinsky EP
    Br J Haematol; 2006 May; 133(4):433-5. PubMed ID: 16643452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rare causes of decreased thromboplastin values].
    Lutze G; Urbahn H
    Z Gesamte Inn Med; 1988 Mar; 43(5):113-6. PubMed ID: 3291424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
    George E; Wong HB
    Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorheological changes in blood transfusion-treated beta thalassemia major patients.
    Mangalani M; Lokeshwar MR; Banerjee R; Nageswari K; Puniyani RR
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):99-102. PubMed ID: 9699030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the basics of beta thalassemia major.
    Martin MB; Butler RB
    Pediatr Nurs; 1993; 19(2):143-5. PubMed ID: 8502496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of the assays for the measurement of clotting factor activity in the presence of rivaroxaban.
    Gerotziafas GT; Baccouche H; Sassi M; Galea V; Chaari M; Hatmi M; Samama MM; Elalamy I
    Thromb Res; 2012 Jan; 129(1):101-3. PubMed ID: 22000405
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights.
    Musallam KM; Khoury B; Abi-Habib R; Bazzi L; Succar J; Halawi R; Hankir A; Koussa S; Taher AT
    Eur J Haematol; 2011 Jul; 87(1):73-9. PubMed ID: 21480999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.